Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 57664-710

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 57664-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Mpd Er 72 mg Figure 1)

Fig1 (Mpd Er 72 mg Figure 1)
A line graph comparing mean plasma methylphenidate concentration (ng/ml) over time (hours) for two dosing regimens: Methylphenidate Hydrochloride Extended-Release Tablets 18 mg once daily and Methylphenidate 5 mg three times daily. The graph shows concentration changes from 0 to 32 hours post-dose.*
FDA Label Image

Fig2 (Mpd Er 72 mg Figure 2)

Fig2 (Mpd Er 72 mg Figure 2)
A bar chart comparing maximum symptoms on the Inattention/Overactivity Scale between Methylphenidate Hydrochloride Extended-Release Tablets once daily and placebo across three studies. The vertical axis ranges from No Symptoms to Maximum Symptoms, with Methylphenidate showing lower symptom scores than placebo in all studies.*
FDA Label Image

Fig3 (Mpd Er 72 mg Figure 3)

Fig3 (Mpd Er 72 mg Figure 3)
A line graph depicting combined attention subscale scores over 12 hours post initial dose for two groups: Methylphenidate Hydrochloride Extended-Release Tablets Once Daily and placebo. The y-axis measures attention levels (more attentive at bottom, less attentive at top), and the x-axis shows hours post dose. The graph compares attention changes between the medication and placebo groups over time.*
FDA Label Image

Mpd-er-72mg (Mpd Er 72mg 30ct)

Mpd-er-72mg (Mpd Er 72mg 30ct)
Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP 72 mg by Sun Pharmaceutical Industries, Inc. The label includes the NDC 57664-710, states the package contains 30 tablets, and directs users to the medication guide online. Storage instructions and caution about child-resistant packaging are also present.*
FDA Label Image

Structure (Methylphenidate 01)

Structure (Methylphenidate 01)
Chemical structure of Methylphenidate Hydrochloride showing the molecular arrangement including a benzene ring, ester group, piperidine ring, and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.